Folic Acid and Vitamins D and B12 Correlate with Homocysteine in Chinese Patients with Type-2 Diabetes Mellitus, Hypertension, or Cardiovascular Disease

Medicine (United States)

Volumn 95, Issue 6, 2016, Pages

  Mao, Xudong ^a   Xing, Xubin ^d   Xu, Rong ^a   Gong, Qing ^a   He, Yue ^a   Li, Shuijun ^b   Wang, Hongfu ^e   Liu, Cong ^c   Ding, Xin ^c   Na, Rishu ^c   Liu, Zhiwen ^c   Qu, Yi ^a  

^a Department of Geriatrics ^*  (China)

^b Central Laboratory   (China)

^c Shanghai Xuhui Central Hospital   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCIFEDIOL; COLECALCIFEROL; CREATININE; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; HOMOCYSTEINE; VITAMIN D;

AGED; ARTERIOSCLEROSIS; ARTICLE; CARDIOVASCULAR DISEASE; CHINESE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; ICD-9; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENESCENCE; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; COMPLICATION; DIETARY SUPPLEMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; VITAMIN B 12; VITAMIN D;

EID: 84958267535     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002652     Document Type: Article

References (40)

1. Bloomfield GS, Wang TY, Boulware LE, et al. Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseases. Glob Heart. 2015; 10: 31-38.
2. Guoqiang G, Liu R, Zhang G, et al. GW25-e4118 The relationship between folic acid, vitamin B12, blood pressure variability and the degree of cysteine. J Am Coll Cardiol. 2014; 64: C174.
3. Boucher BJ. Vitamin D insufficiency and diabetes risks. Curr Drug Targets. 2011; 12: 61-87.
4. Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr. 1998; 67: 1108-1110.
5. Fernandes de Abreu DA, Eyles D, Feron F. Vitamin D, a neuroimmunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009; 34(Suppl 1): S265-277.
6. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-Analysis. J Clin Endocrinol Metab. 2007; 92: 2017-2029.
7. Brewer LC, Michos ED, Reis JP. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets. 2011; 12: 54-60.
8. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008; 52: 828-832.
9. Adaikalakoteswari A, Jayashri R, Sukumar N, et al. Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes. Cardiovasc Diabetol. 2014; 13: 129.
10. Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT randomized clinical trial. JAMA. 2015; 313: 1325-1335.
11. Homocysteine Lowering Trialists C. Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-Analysis of the randomized trials. Am J Clin Nutr. 2005; 82: 806-812.
12. Prins ND, Den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study. Neurology. 2002; 59: 1375-1380.
13. van Guldener C, Nanayakkara PW, Stehouwer CD. Homocysteine and blood pressure. Curr Hypertens Rep. 2003; 5: 26-31.
14. Homocysteine Studies C. Homocysteine and risk of ischemic heart disease and stroke: A meta-Analysis. JAMA. 2002; 288: 2015-2022.
15. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015; 14: 6.
16. Huang T, Ren J, Huang J, et al. Association of homocysteine with type 2 diabetes: A meta-Analysis implementing Mendelian randomization approach. BMC Genomics. 2013; 14: 867.
17. Sudchada P, Saokaew S, Sridetch S, et al. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: A systematic review and meta-Analysis. Diabetes Res Clin Pract. 2012; 98: 151-158.
18. Agullo-Ortuno MT, Albaladejo MD, Parra S, et al. Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clin Chim Acta. 2002; 326: 105-112.
19. Li J, Zhang H, Shi M, et al. Homocysteine is linked to macular edema in type 2 diabetes. Curr Eye Res. 2014; 39: 730-735.
20. Chan KW. Misconceptions and complexities in the study of Chinas cities: definitions, statistics, and implications. Eurasian Geogr Econ. 2007; 48: 383-412.
21. de Koning L, Al-Turkmani MR, Berg AH, et al. Variation in clinical vitamin D status by DiaSorin Liaison and LC-MS/MS in the presence of elevated 25-OH vitamin D2. Clin Chim Acta. 2013; 415: 54-58.
22. Yu S, Fang H, Han J, et al. The high prevalence of hypovitaminosis D in China: A multicenter vitamin D status survey. Medicine (Baltimore). 2015; 94: e585.
23. Li S, Jia J, Liu G, et al. Improved and simplified LC-ESI-MS/MS method for homocysteine determination in human plasma: Application to the study of cardiovascular diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 870: 63-67.
24. Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med. 2000; 342: 905-912.
25. van den Ouweland JM, Beijers AM, Demacker PN, et al. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci. 2010; 878: 1163-1168.
26. Jiang L, Xu J, Pan S, et al. High prevalence of hypovitaminosis D among pregnant women in southeast China. Acta Paediatr. 2012; 101: e192-e194.
27. Lu HK, Zhang Z, Ke YH, et al. High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover. PLoS One. 2012; 7: e47264.
28. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007; 49: 1063-1069.
29. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117: 503-511.
30. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56: 111-128.
31. McCully KS. Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: A key case revisited. Nutr Rev. 1992; 50: 7-12.
32. Franco MC, Higa EM, DAlmeida V, et al. Homocysteine and nitric oxide are related to blood pressure and vascular function in smallfor-gestational-Age children. Hypertension. 2007; 50: 396-402.
33. Emoto M, Kanda H, Shoji T, et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care. 2001; 24: 533-538.
34. Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis. 1993; 103: 149-157.
35. Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1998; 98: 204-210.
36. Smulders YM, Rakic M, Slaats EH, et al. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care. 1999; 22: 125-132.
37. Mazza A, Bossone E, Mazza F, et al. Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis. 2005; 15: 118-124.
38. Oishi K, Nagake Y, Yamasaki H, et al. The significance of serum homocysteine levels in diabetic patients on haemodialysis. Nephrol Dial Transplant. 2000; 15: 851-855.
39. Bazzano LA, He J, Ogden LG, et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke. 2002; 33: 1183-1188.
40. Van Guelpen B, Hultdin J, Johansson I, et al. Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: A prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke. 2005; 36: 1426-1431.